Examines the risks of insertional oncogenesis in gene therapy. Gene therapy of x-linked severe-combined immune deficiency; Oncogene transactivation; Oncogene cooperativity and the two-hits-in-one hypothesis; Early assessment of risk factors for insertional oncogenesis; Remedies against insertional oncogenesis.